MadduxMS, BarriereSL. A review of complications of amphotericin B therapy: recommendations for prevention and management.Drug Intell Clin Pharm1980; 14: 17781.
2.
BullockWE, LuckRG, NuttallCE, BhathenaD. Can mannitol reduce amphotericin B nephrotoxicity? Double blind study and description of a new vascular lesion in kidneys.Antimicrob Agents Chemother1976; 10: 5563.
3.
HellebuschAA, SalamaF, EadieE. The use of mannitol to reduce the nephrotoxicity of amphotericin B.Surg Gynecol Obstet1972; 134: 2413.
4.
OliveroJJ, Lozano-MendezJ, GhafaryEM, EknoyanG, SukiWN. Mitigation of amphotericin B nephrotoxicity with mannitol.Br Med J1975; 1: 5501.
5.
RoschJM, PazinGJ, FiremanP. Reduction of amphotericin B nephrotoxicity with mannitol.JAMA1976; 236: 19956.
6.
WilliamsTW, OliveroJJ, WestermanEL, SmilackJD. Mannitol and amphotericin B (letter).JAMA1976; 236: 1118.
7.
GoodwinWE, LattaH. Focal osmotic nephrosis due to the therapeutic use of mannitol: a case of perirenal hematoma after renal biopsy.J Urol1970; 103: 114.
